Shiozawa Shunichi, Tsuchiya Akira, Endo Shungo, Kato Hiroyuki, Katsube Takao, Kumazawa Kenichi, Naritaka Yoshihiko, Ogawa Kenji
Department of Surgery, Tokyo Women's Medical University, Daini Hospital, Japan.
J Clin Gastroenterol. 2003 Nov-Dec;37(5):412-7. doi: 10.1097/00004836-200311000-00013.
We evaluated the clinical usefulness and safety of transradial approach for transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) compared with that of conventional transfemoral approach. The two groups (radial group, n = 177; femoral group, n = 150) of cases were retrospectively compared with regard to the successful rate of angiography or TACE, time required for catheterizaiton and complications. Hepatic angiography and TACE were completed in 174 (98.3%) of 177 cases in the radial group. There was no intergroup difference of time required for catheterization. Minor complications (dull pain, numbness) occurred in 8 (4.6%) patients in the radial group, and there were lower complications in the radial group compared to the femoral group. TACE by our new transradial approach was found to have therapeutic efficacy with lower complications comparable to that of the conventional transfemoral approach.
我们评估了经桡动脉途径与传统经股动脉途径在肝细胞癌（HCC）患者经导管动脉化疗栓塞术（TACE）中的临床实用性和安全性。回顾性比较了两组病例（桡动脉组，n = 177；股动脉组，n = 150）在血管造影或TACE成功率、插管所需时间和并发症方面的情况。桡动脉组177例中有174例（98.3%）完成了肝血管造影和TACE。两组插管所需时间无差异。桡动脉组有8例（4.6%）患者出现轻微并发症（钝痛、麻木），且桡动脉组并发症低于股动脉组。我们的新经桡动脉途径TACE被发现具有治疗效果，并发症发生率较低，与传统经股动脉途径相当。
